Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Fagan

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2013
Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic strokeMaha Coucha, Weiguo Li, Maribeth H Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 19, 2008
Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response studyWieslaw Kozak, Anna Kozak, Maribeth H Johnson, et al.
Experimental & Translational Stroke Medicine|February 7, 2014
Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the responseAbdelrahman Y Fouda, Anna Kozak, Ahmed Alhusban, et al.
Journal of Hypertension|March 14, 2007
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protectionHazem F Elewa, Anna Kozak, Maribeth H Johnson, et al.
Neurochemical Research|August 9, 2018
Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral IschemiaTauheed Ishrat, Sahar Soliman, Wael Eldahshan, et al.
European Journal of Pharmacology|February 14, 2017
Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injuryAbdelrahman Y Fouda, Bindu Pillai, Krishnan M Dhandapani, et al.
Translational Stroke Research|June 5, 2013
Recommendations for preclinical research in hemorrhagic transformationSusan C Fagan, Paul A Lapchak, David S Liebeskind, et al.
Pharmacotherapy|January 27, 2010
Diverse effects of statins on angiogenesis: new therapeutic avenuesHazem F Elewa, Azza B El-Remessy, Payaningal R Somanath, et al.
Drugs in R&D|May 18, 2019
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USAStephanie V Phan, Sharmon Osae, John C Morgan, et al.
Journal of the American Pharmacists Association : Japha|April 21, 2004
New perspectives on the pharmacotherapy of ischemic strokeJ Chris Bradberry, Susan C Fagan, David R Gray, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
American Journal of Physiology. Heart and Circulatory Physiology|October 8, 2013
Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic strokeMaha Coucha, Weiguo Li, Maribeth H Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 19, 2008
Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response studyWieslaw Kozak, Anna Kozak, Maribeth H Johnson, et al.
Experimental & Translational Stroke Medicine|February 7, 2014
Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the responseAbdelrahman Y Fouda, Anna Kozak, Ahmed Alhusban, et al.
Journal of Hypertension|March 14, 2007
Blood pressure lowering after experimental cerebral ischemia provides neurovascular protectionHazem F Elewa, Anna Kozak, Maribeth H Johnson, et al.
Neurochemical Research|August 9, 2018
Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral IschemiaTauheed Ishrat, Sahar Soliman, Wael Eldahshan, et al.
European Journal of Pharmacology|February 14, 2017
Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia/reperfusion injuryAbdelrahman Y Fouda, Bindu Pillai, Krishnan M Dhandapani, et al.
Translational Stroke Research|June 5, 2013
Recommendations for preclinical research in hemorrhagic transformationSusan C Fagan, Paul A Lapchak, David S Liebeskind, et al.
Pharmacotherapy|January 27, 2010
Diverse effects of statins on angiogenesis: new therapeutic avenuesHazem F Elewa, Azza B El-Remessy, Payaningal R Somanath, et al.
Drugs in R&D|May 18, 2019
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USAStephanie V Phan, Sharmon Osae, John C Morgan, et al.
Journal of the American Pharmacists Association : Japha|April 21, 2004
New perspectives on the pharmacotherapy of ischemic strokeJ Chris Bradberry, Susan C Fagan, David R Gray, et al.
Pageof 14